Intellia Therapeutics
NTLA
NTLA
240 hedge funds and large institutions have $3.36B invested in Intellia Therapeutics in 2020 Q4 according to their latest regulatory filings, with 93 funds opening new positions, 68 increasing their positions, 50 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
240
Holders Change
+75
Holders Change %
+45.45%
% of All Funds
4.26%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
93
Increased
68
Reduced
50
Closed
17
Calls
$16.9M
Puts
$83.1M
Net Calls
-$66.2M
Net Calls Change
-$68.1M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$63.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$41M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$36.1M |
| 4 |
Goldman Sachs
New York
|
+$28.2M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$26.1M |
Top Sellers
| 1 |
NAMA
Nikko Asset Management Americas
New York
|
-$52.1M |
| 2 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$52.1M |
| 3 |
State Street
Boston,
Massachusetts
|
-$44.4M |
| 4 |
BlackRock
New York
|
-$32.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$27.6M |
